Literature DB >> 18818871

Porcine endogenous retroviruses and xenotransplantation.

C A Wilson1.   

Abstract

Xenotransplantation is defined by the PHS as any procedure that involves the transplantation, implantation or infusion into a human recipient of either (a) live cells, tissues or organs from a nonhuman animal source, or (b) human body fluids, cells, tissues or organs that have had ex vivo contact with live nonhuman animal cells, tissues or organs (Public Health Service Guideline on Infectious Disease Issues in Xenotransplantation). Use of pigs for human xenotransplantation raises concerns about the risks of transfer of infectious agents from the pig cells to xenotransplantation recipients. The observation that the porcine germline harbors genetic loci encoding porcine endogenous retroviruses (PERVs) that are in some cases infectious for human cells has resulted in renewed scientific interest in PERVs. However, in spite of the past 10 years of investigation, the actual risk for PERV infection, replication, and pathogenic outcome in human recipients of xenotransplantation products is still undefined. (Part of a multi-author review).

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18818871     DOI: 10.1007/s00018-008-8498-z

Source DB:  PubMed          Journal:  Cell Mol Life Sci        ISSN: 1420-682X            Impact factor:   9.261


  38 in total

Review 1.  The good viruses: viral mutualistic symbioses.

Authors:  Marilyn J Roossinck
Journal:  Nat Rev Microbiol       Date:  2011-01-04       Impact factor: 60.633

2.  Isolation of an infectious endogenous retrovirus in a proportion of live attenuated vaccines for pets.

Authors:  Takayuki Miyazawa; Rokusuke Yoshikawa; Matthew Golder; Masaya Okada; Hazel Stewart; Massimo Palmarini
Journal:  J Virol       Date:  2010-01-27       Impact factor: 5.103

3.  Influence of chitosan nanofiber scaffold on porcine endogenous retroviral expression and infectivity in pig hepatocytes.

Authors:  Bing Han; Xiao-Lei Shi; Jiang-Qiang Xiao; Yue Zhang; Xue-Hui Chu; Jin-Yang Gu; Jia-Jun Tan; Zhong-Ze Gu; Yi-Tao Ding
Journal:  World J Gastroenterol       Date:  2011-06-14       Impact factor: 5.742

4.  A bioartificial liver device based on three-dimensional culture of genetically engineered hepatoma cells using hollow fibers.

Authors:  Yusuke Fujii; Kengo Higashi; Hiroshi Mizumoto; Masamichi Kamihira; Toshihisa Kajiwara
Journal:  Cytotechnology       Date:  2020-02-04       Impact factor: 2.058

5.  Restricted replication of xenotropic murine leukemia virus-related virus in pigtailed macaques.

Authors:  Gregory Q Del Prete; Mary F Kearney; Jon Spindler; Ann Wiegand; Elena Chertova; James D Roser; Jacob D Estes; Xing Pei Hao; Charles M Trubey; Abigail Lara; Kyeongeun Lee; Chawaree Chaipan; Julian W Bess; Kunio Nagashima; Brandon F Keele; Rhonda Macallister; Jeremy Smedley; Vinay K Pathak; Vineet N Kewalramani; John M Coffin; Jeffrey D Lifson
Journal:  J Virol       Date:  2012-01-11       Impact factor: 5.103

6.  Regulation of porcine endogenous retrovirus release by porcine and human tetherins.

Authors:  Giada Mattiuzzo; Sabrina Ivol; Yasuhiro Takeuchi
Journal:  J Virol       Date:  2009-12-16       Impact factor: 5.103

Review 7.  Islet cell xenotransplantation: a serious look toward the clinic.

Authors:  Kannan P Samy; Benjamin M Martin; Nicole A Turgeon; Allan D Kirk
Journal:  Xenotransplantation       Date:  2014-05-08       Impact factor: 3.907

8.  Detection of a gammaretrovirus, XMRV, in the human population: open questions and implications for xenotransplantation.

Authors:  Joachim Denner
Journal:  Retrovirology       Date:  2010-03-10       Impact factor: 4.602

Review 9.  Fertility preservation for boys with cancer.

Authors:  Kazutoshi Fujita; Akira Tsujimura
Journal:  Reprod Med Biol       Date:  2010-08-07

10.  Presence of a Shared 5'-Leader Sequence in Ancestral Human and Mammalian Retroviruses and Its Transduction into Feline Leukemia Virus.

Authors:  Junna Kawasaki; Maki Kawamura; Yoshiharu Ohsato; Jumpei Ito; Kazuo Nishigaki
Journal:  J Virol       Date:  2017-09-27       Impact factor: 5.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.